Metraipolis › archive › dc_5cc36675e2e4

FGFR3-TACC3 fusion as a potential primary resistance mechanism to EGFR-TKI in lung adenocarcinoma harboring co-driven mutations: a case report — Europe PMC PMID:41907614

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41907614
DOI: 10.3389/fonc.2026.1780493
License (as archived): solo-consultazione
Archived: 2026-11-04T11:34:53.725Z
SHA-256 of the archived text: 4d0ab5cca681787b04cd7078c9c5f04451998184dce9f93999d17e96527209d9
Stable URL of this page: https://metraipolis.com/documento/dc_5cc36675e2e4

How to cite

FGFR3-TACC3 fusion as a potential primary resistance mechanism to EGFR-TKI in lung adenocarcinoma harboring co-driven mutations: a case report — Europe PMC PMID:41907614 — Europe PMC (en), https://europepmc.org/article/MED/41907614 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5cc36675e2e4 (Metraipolis archive dc_5cc36675e2e4, sha256 4d0ab5cca681787b04cd7078c9c5f04451998184dce9f93999d17e96527209d9)

BibTeX

@misc{dc5cc36675e2e4,
  title = {FGFR3-TACC3 fusion as a potential primary resistance mechanism to EGFR-TKI in lung adenocarcinoma harboring co-driven mutations: a case report — Europe PMC PMID:41907614},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41907614},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5cc36675e2e4; sha256 4d0ab5cca681787b04cd7078c9c5f04451998184dce9f93999d17e96527209d9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41907614. Agents can read the archived copy with the MCP tool read_document.